查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球心電圖監測儀市場
市場調查報告書
商品編碼
1146428

2022-2029 年全球心電圖監測儀市場

Global Cardiac Holter Monitor Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

心臟動態監測儀的市場規模預計到 2021 年將達到 4.11 億美元，到 2029 年將達到 5.77 億美元，在預測期內（2022-2029 年）以 5.4% 的複合年增長率增長。

動態心電監護儀是一種持續監測設備，可以對患者的心臟進行短期（24 到 48 小時）監測，有些監測儀的使用期限長達 14 天。 ECG Holter 監測器是第一個動態心臟監測器，用於在沒有靜息 ECG 監測器的情況下進行長期心臟監測。 Holter 監視器因其適用於門診實踐而在世界範圍內被廣泛接受。

市場動態

由於對長期患者監測的需求不斷增長和門診費用的降低，心臟動態心電圖監測儀的全球市場正在增長，而心血管疾病患病率的上升推動了近年來心臟動態心電圖監測儀的增長。

心血管疾病患病率上升推動市場增長

血管成形術被推薦用於治療外周血管疾病。在此過程中，心臟導管用於探查受影響的動脈並使動脈再通以消除動脈壁的阻塞。根據美國心臟協會的一項研究，到 2020 年，將有 9210 萬美國人患有某種形式的 CVD，這使得 CVD 成為美國的頭號死因，而不是癌症和其他慢性病。

在世界發展中國家，老年人口的增加是主要問題之一。此外，預計在未來一段時間內，老年人慢性疾病的患病率將會增加，例如主動脈疾病、靜脈血栓栓塞症和外周動脈疾病。根據美國疾病控制和預防中心的數據，到 2020 年，全球 55 至 65 歲人口中將有超過 19.1% 的人患有外周血管疾病，據推測，大約 27% 的男性和超過 21% 的女性會受到影響。亞太地區是老年人口最集中的地區，而且這一數字正以歷史最高水平增長。

預計嚴格的政府法規會阻礙市場增長

對於現有企業，我們預計技術增強型手持設備的價格壓力會越來越大，這些設備比標準 ECG 更具成本效益。此外，由於現行政府法規導致的較低報銷率預計會影響產品成本。例如，2021 年 11 月，當 2022 年 Medicare 醫師費用表最終規則發佈時，全面的外部 ECG 監測再次從定價討論中刪除。這可能會降低小工具的醫療保險費率，這將對其採用產生負面影響。

COVID-19 影響分析

由於治療、診斷和手術等服務被暫停以阻止 COVID-19 疾病的傳播，預計 COVID-19 流行病將對全球導管行業的增長產生短期負面影響。預測.據國家醫學圖書館稱，約旦實施了與 COVID-19 相關的嚴格封鎖。心血管治療量在嚴格的封鎖期間急劇下降，並在部分放鬆封鎖後逐漸增加。然而，隨著政府和醫療機構繼續加強對 COVID-19 患者的護理，導管將在醫院中更頻繁地使用。

行業分析

全球心臟動態心電圖監測儀市場基於各種行業因素，如波特五力、監管分析、供應鍊和定價分析、報銷政策、技術進步、PEST 分析等。

細分市場分析

無線動態心電監護儀細分市場有望在全球心臟動態心電監護儀市場佔據最大市場份額

無線動態心電監護儀主要用於監測患有心悸、室性心動過速和房顫的患者。這得益於它在大中型醫院廣泛用於心血管疾病患者的診斷。

擴展型動態心電技術（貼片）是一種無需電線的長效動態心電設備。使用 2 盤技術，您需要使用藍牙技術將數據同步到遠程設備。根據 2018 年 3 月 19 日在奧蘭多舉行的美國心髒病學會第 67 屆年度科學會議上公佈的為期一年的數據，對於那些心房顫動 (AFib) 風險增加的人，發現佩戴記錄心臟模式的自粘胸貼與依賴常規護理相比，可以更好地檢測醫療狀況並促進更及時的治療。

據研究人員稱，這項名為預防中風的移動健康篩查 (mSToPS) 試驗的研究是第一個完全數位化、全國性、直接面向參與者、無地點的臨床研究項目。患者同意並通過基於網絡的平台註冊，以便在家中使用 iRhythm Zio 貼片進行主動監測。該貼片可連續記錄心電圖（檢測心房顫動的金標準），大小與創可貼差不多。此外，心電圖記錄貼片對於檢測心房顫動必不可少，製造商正在推出創新、小型化和更方便的產品。例如，iRhythm 的 Zio XT 貼片將動態心電圖監測器整合到一個小巧的計步器大小的粘性設備中。只需將其貼在胸壁上，即可連續監測 14 天的心率。

區域分析

北美在全球心臟動態心電監護儀市場中佔據最大的市場份額。

北美將在 2021 年主導全球心臟動態心電監護儀市場。這一巨大的收入份額主要是由於心血管疾病患病率上升等原因所致。心臟相關疾病和相關生活方式疾病的增加正在推動北美心臟監測市場，技術開發、產品發布和製造商之間的合作協議的增加推動了新產品開發的增長，而不斷增加的產品組合反過來又增加了市場機會。預計市場還將受到各種市場參與者和美國政府在開發和商業化各種易於使用的設備方面增加投資的推動。例如，2018 年 5 月，Preventis Solutions 推出了 BodyGuardian Mini，這是一種用於心臟監測的可重複使用、長期和最小的 Holter 技術。這項新技術包括一個超緊湊的心臟監測器，可以測量心電圖長達 14 天，並可以將數據以易於閱讀的報告形式傳輸給您的醫生。因此，此類滿足醫生和患者需求的技術先進產品的推出有望在未來幾年推動市場增長。

競爭格局

心臟動態心電監護儀市場是一個競爭激烈的市場，一些業內最大的參與者進入了這個市場。為全球市場增長做出貢獻的主要心臟動態心電監護儀參與者包括 Medtronic Plc, GE Healthcare, Spacelabs Healthcare, FUKUDA DENSHI CO.LTD., Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., Schiller AG, BTL, Koninklijke Philips N.V., ScottCare Corporation.。

全球心臟動態心電圖監測市場——值得關注的主要參與者

美敦力公司

概述美敦力公司是一家製造和銷售醫療器械的美國公司，總部位於美國明尼阿波利斯。它在大約 140 個國家開展業務，擁有 90,000 名員工。

產品組合 Reveal LINQ 系統包括一個佩戴在皮膚下的小型可插入監視器和一個 MyCareLink 患者監視器。

這份報告提供了大約 45+ 市場數據表、40+ 圖表和 180 頁關於全球心臟動態心電監護儀市場的資訊。

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品類型細分的市場
  • 按組件細分的市場
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 心血管疾病患者人數增加
      • 各國政府對研發的重大投資
      • 更加註重預防/診斷保健
    • 抑制因素
      • 設備成本高
      • 缺乏熟練的技術人員
    • 影響分析

第 5 章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析

第 6 章產品類型分析

  • 1 個頻道
  • 2 個頻道
  • 3 個頻道
  • 12 個頻道
  • 其他

第 7 章（按組件）

  • 無線掛脖
  • 有線掛脖
  • Holter 分析系統/軟件

第 8 章最終用戶

  • 醫院
  • 門診手術中心
  • 醫務室
  • 家庭醫療

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 按產品類型進行組合比較分析
  • 市場定位/市場份額分析
  • 併購分析

第 11 章公司簡介

  • ScottCare Corporation
    • 公司簡介
    • 按產品類型分類的產品組合和說明
    • 主要亮點
    • 財務摘要
  • Medtronic Plc
  • GE Healthcare
  • Spacelabs Healthcare
  • FUKUDA DENSHI CO.LTD
  • Nasiff Associates, Inc
  • Biomedical Instruments Co., Ltd
  • Schiller AG
  • BTL
  • Koninklijke Philips N.V

第 12 章心臟動態心電圖監測儀的全球市場-DataM

簡介目錄
Product Code: DMMD1453

Market Overview

Cardiac Holter Monitor Market size was valued US$ 411 million in 2021 and is estimated to reach US$ 577 million by 2029, growing at a CAGR of 5.4% during the forecast period (2022-2029).

Holter monitor is a continuous monitoring device that monitors a patient's heart for a short period (24 hours to 48 hours); some were prescribed for up to 14 days. ECG Holter monitors the first ambulatory cardiac monitor and is used for more extended period monitoring of the heart, where a resting ECG monitor cannot be used. Holter monitors have gained greater acceptance globally due to their suitable application for ambulatory services.

Market Dynamics

The global cardiac holter monitor market is growing due to the increasing need for longer period patient monitoring and reduced cost of care for ambulatory settings, rising prevalence of cardiovascular diseases is driving the growth for cardiac holter monitors in the recent years.

Rising prevalence of cardiovascular diseases drives the growth of the market

For the treatment of peripheral vascular disorders, angioplasty is advised. During this operation, the afflicted artery is examined using a cardiac catheter, which reopens the artery and flattens the blockage in the artery wall. In contrast to cancer and other chronic diseases, the American Heart Association research estimates that 92.1 million Americans were living with some type of CVD in 2020 and that CVD is the leading cause of death in the nation.

One of the main issues in developing nations worldwide is the growing senior population. Additionally, an expected period of time would see a growth in the prevalence of chronic diseases in geriatric individuals, including aortic disease, venous thromboembolism, peripheral arterial disease, etc. In 2020, more than 19.1% of the world's population of seniors aged 55 to 65 had peripheral vascular disease, with about 27% of men and more than 21% of women affected, according to a report from the Centers for Disease Control and Prevention. The largest concentration of senior citizens is in Asia and the Pacific, and their numbers are growing at an unprecedented rate.

The stringent government rules are expected to hamper the market growth

For established companies, rising price pressure from technologically improved and portable devices that are more cost-effective than standard ECG is anticipated. In addition, a decline in reimbursement rates from current government rules is expected to impact product costs. For instance, when the Medicare Physician Fee Schedule Final Rule for 2022 was published in November 2021, comprehensive external ECG monitoring was again left out of the pricing discussion. This will probably result in lower Medicare rates for gadgets, which will have an adverse effect on their uptake.

COVID-19 Impact Analysis

Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheters industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organisations continue to enhance medical care for COVID-19 patients, catheters will be utilised more frequently in hospitals.

Industry Analysis

The global cardiac holter monitor market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The wireless holter monitors segment is expected to hold the largest market share in global cardiac holter monitor market

The wireless holter monitors are majorly incorporated in monitoring of patients suffering from palpitation, ventricular tachycardia, and atrial fibrillation. This is attributed to its large-scale utilization in large and mid-sized hospitals for the diagnosis of patients suffering from cardiovascular diseases.

Extended Holter Technology (Patch) is a long-term wearable holter device that does not require wires. It is a two-piece technology that needs data to sync to a remote device via Bluetooth technology. According to one-year data presented at the American College of Cardiology's 67th Annual Scientific Session, in Orlando, on March 19, 2018, for people at heightened risk for atrial fibrillation (AFib), wearing a self-adhering chest patch that records heart patterns may better detect the condition and facilitate more timely treatment than relying on usual care.

The study, called the mHealth Screening to Prevent Strokes (mSToPS) trial, is one of the first completely digital, nationwide, direct-to-participant and site-less clinical research programs, according to researchers. Patients consented and enrolled exclusively via a web-based platform to undergo active monitoring at home using the iRhythm Zio patch. The patch about the size of a large Band-Aid continuously records an electrocardiogram (ECG), the gold standard for detecting AFib. In line with this, manufacturers are introducing innovative and miniaturized products that offer enhanced convenience. For instance, Zio XT Patch, iRhythm, it incorporates the holter monitor into a small pedometer-sized device with an adhesive backing. A 14-day continuous cardiac rhythm monitoring with a single adhesive chest wall device can be done.

Geographical Analysis

North America region holds the largest market share in the global cardiac holter monitor market

North America was held a dominant position in the global cardiac holter monitor market in 2021. This large revenue share is mainly due to the rising prevalence of cardiovascular diseases, among other things. Rising heart related diseases and associated lifestyle diseases is driving the market for cardiac monitoring market in North America, increasing technological developments, product launches, and collaborative agreements among manufacturers are driving the growth for new product developments, which increasing product portfolio in turn enhances market opportunity. Increase in investment by various market players and the U.S. government for development and commercialization of various easy-to-use equipment is also likely to drive the market. For instance, in May 2018, Preventice Solutions launched BodyGuardian Mini, a reusable long-term and smallest Holter technology for cardiac monitoring. The new technology includes an ultra-small cardiac monitor that can measure ECG up to 14 days and can transfer data to a physician in an easy-to-read report. Hence, launch of such technologically advanced products to address the needs of physicians and patients is expected to boost market growth in the coming years.

Competitive Landscape

The cardiac holter monitor market is highly competitive, owing to big market players in the industry. The key cardiac holter monitor players which are contributing to the growth of the global market include Medtronic Plc, GE Healthcare, Spacelabs Healthcare, FUKUDA DENSHI CO.LTD., Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., Schiller AG, BTL, Koninklijke Philips N.V., ScottCare Corporation.

Global Cardiac Holter Monitor Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: The Reveal LINQ system includes a tiny insertable monitor placed just under the skin and the MyCareLink patient monitor.

The global cardiac holter monitor market report would provide an access to an approx. 45+ market data table, 40+ figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Components
  • 3.3. Market Snippet by End-user
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the number of patients subjected to cardiovascular diseases
      • 4.1.1.2. Significant investment in research and development by the governments
      • 4.1.1.3. Rising focus on preventive and diagnostic healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Higher costs of devices
      • 4.1.2.2. Lack of skilled technicians
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis

6. By Product type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
  • 6.3. Market Attractiveness Index, By Product type
    • 6.3.1. 1-Channel *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.3.2. 2-Channel
    • 6.3.3. 3-Channel
    • 6.3.4. 12-Channel
    • 6.3.5. Others

7. By Components

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
  • 7.3. Market Attractiveness Index, By Components
    • 7.3.1. Wireless Holter*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.3.2. Wired Holter
    • 7.3.3. Holter Analysis System & Software

8. By End-user

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  • 8.3. Market Attractiveness Index, By End-user
    • 8.3.1. Hospitals *
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Clinics
    • 8.3.4. Homecare Settings

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Comparative Product type Portfolio Analysis
  • 10.3. Market Positioning/Share Analysis
  • 10.4. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. ScottCare Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Medtronic Plc
  • 11.3. GE Healthcare
  • 11.4. Spacelabs Healthcare
  • 11.5. FUKUDA DENSHI CO.LTD
  • 11.6. Nasiff Associates, Inc
  • 11.7. Biomedical Instruments Co., Ltd
  • 11.8. Schiller AG
  • 11.9. BTL
  • 11.10. Koninklijke Philips N.V

LIST NOT EXHAUSTIVE

12. Global Cardiac Holter Monitor Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us